We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-15.67%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$4.98B
AUM Growth
-$1.04B
Cap. Flow
+$50.1M
Cap. Flow %
1.01%
Top 10 Hldgs %
30.66%
Holding
1,260
New
93
Increased
866
Reduced
230
Closed
68

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$40.1M
2
PG icon
Procter & Gamble
PG
+$19.2M
3
MRK icon
Merck
MRK
+$12.2M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$10.3M
5
IBM icon
IBM
IBM
+$9.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$37.9M
2
AAPL icon
Apple
AAPL
+$19.7M
3
MSFT icon
Microsoft
MSFT
+$14.9M
4
HD icon
Home Depot
HD
+$14.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.67M

Sector Composition

Rank Sector Weight
1 Technology 29.34%
2 Healthcare 13.95%
3 Consumer Discretionary 12.19%
4 Financials 10.87%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBGS
1001
JBG SMITH
JBGS
$715M
$310K 0.01%
13,117
+458
+4% +$11.8K
OMCL icon
1002
Omnicell
OMCL
$1.54B
$308K 0.01%
2,709
+282
+12% +$32.4K
CHPT icon
1003
ChargePoint
CHPT
$151M
$307K 0.01%
+1,120
New +$310K
WAFD icon
1004
WaFd
WAFD
$2.68B
$304K 0.01%
10,133
+570
+6% +$17.9K
DAN icon
1005
Dana Inc
DAN
$3.28B
$301K 0.01%
21,428
+359
+2% +$5.57K
STAG icon
1006
STAG Industrial
STAG
$7.19B
$301K 0.01%
9,763
+1,238
+15% +$43.9K
NEWR
1007
DELISTED
New Relic, Inc.
NEWR
$301K 0.01%
6,004
-152
-2% -$8.44K
CBRL icon
1008
Cracker Barrel
CBRL
$1.26B
$300K 0.01%
3,599
+134
+4% +$13.9K
KMT icon
1009
Kennametal
KMT
$2.31B
$299K 0.01%
12,850
+700
+6% +$18.4K
NAVI icon
1010
Navient
NAVI
$886M
$298K 0.01%
21,271
-1,213
-5% -$18.9K
INSP icon
1011
Inspire Medical Systems
INSP
$1.75B
$297K 0.01%
1,627
+186
+13% +$37.1K
CALX icon
1012
Calix
CALX
$2.36B
$296K 0.01%
8,672
+624
+8% +$23.2K
WPC icon
1013
W.P. Carey
WPC
$16.1B
$296K 0.01%
+3,651
New +$295K
TEX icon
1014
Terex
TEX
$7.4B
$295K 0.01%
10,776
+592
+6% +$19.7K
RPRX icon
1015
Royalty Pharma
RPRX
$27.5B
$292K 0.01%
6,955
-16,442
-70% -$674K
SABR icon
1016
Sabre
SABR
$868M
$292K 0.01%
50,152
-17,935
-26% -$150K
ENR icon
1017
Energizer
ENR
$1.53B
$291K 0.01%
10,248
+604
+6% +$18.2K
PCG icon
1018
PG&E
PCG
$40.2B
$291K 0.01%
29,150
+6,822
+31% +$80.2K
ADC icon
1019
Agree Realty
ADC
$9.15B
$290K 0.01%
4,017
+674
+20% +$46.8K
COLM icon
1020
Columbia Sportswear
COLM
$2.94B
$289K 0.01%
4,039
-43
-1% -$3.43K
MAC icon
1021
Macerich
MAC
$6.88B
$289K 0.01%
33,139
+1,773
+6% +$21.4K
BMRN icon
1022
BioMarin Pharmaceuticals
BMRN
$12.6B
$288K 0.01%
+3,472
New +$276K
BFH icon
1023
Bread Financial
BFH
$4.13B
$286K 0.01%
7,730
+2,258
+41% +$115K
SIX
1024
DELISTED
Six Flags Entertainment Corp.
SIX
$284K 0.01%
13,095
+1,538
+13% +$49K
BWXT icon
1025
BWX Technologies
BWXT
$14.2B
$283K 0.01%
5,135
-3,080
-37% -$160K

Similar funds

Xponance's Q2 2022 Portfolio in Review

As of Q2 2022, Xponance held 1,260 positions worth $4.98B, down 17% from $6.01B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Xponance's Q2 2022 filing shows 93 new, 866 increased, 230 reduced and 68 closed positions. Its largest new stake was Warner Bros: 370,598 shares worth $4.97M. The largest sale was Meta Platforms (Facebook), an estimated $37.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Xponance's largest Q2 2022 buy was Warner Bros: 370,598 shares worth $4.97M.
  • Xponance added most to UnitedHealth in Q2 2022, an estimated $40.1M increase.
  • Xponance's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $37.9M.
  • Xponance fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $2.36M.
  • Xponance's ten largest holdings make up 31% of its $4.98B portfolio in Q2 2022.
  • Xponance opened 93 new positions and closed 68 in Q2 2022.
  • Xponance's portfolio value fell 17% quarter-over-quarter to $4.98B.

Based on Xponance's 13F filing for Q2 2022, filed 2 Aug 2022.